PUBLICATIONS

PUBLICATIONS

  • 10

    Diagnostic Performance of Noninvasive Tests in Patients with MetALD in a Health Check-up Cohort

    Journal of Hepatology 2024 Impacf factor: 25.0

    Joo Hyun Oh, Sang Bong Ahn, Seon Cho, Eun-Hee Nah, Eileen L. Yoon, Dae Won Jun

    Link
  • 9

    Do we need a new cut-off for FIB-4 in the metabolic dysfunction-associated fatty liver disease era?

    Journal of Hepatology Impact Factor 25.0 2021

    Huiyul Park, Eileen L. Yoon, Seon Cho, Eun-Hee Nah, Dae Won Jun

    Link
  • 8

    Diabetes is the strongest risk factor of hepatic fibrosis in lean patients with non-alcoholic fatty liver disease.

    GUT 2021 Impacf factor 23.0

    Huiyul Park, Eileen L Yoon, Seon Cho, Dae Won Jun, Eun-Hee Nah

    Link
  • 7

    Prevalence, distribution and hepatic fibrosis burden of the different subtypes of steatotic liver disease in primary care settings

    Hepatology 2024 Impact factor 17.3

    Chul-Min Lee, Eileen L Yoon, Mimi Kim, Bo-Kyeong Kang, Seon Cho, Eun-Hee Nah, Dae Won Jun

    Link
  • 6

    Is lifestyle modification effective for individuals with high fibrosis-4 index without an additional 2nd tier test?

    Hepatology 2023 Impact factor 17.3

    Huiyul Park, Eileen L Yoon, Mimi Kim, Sun-Hong Kwon, Dae Won Jun, Hye-Lin Kim

    Link
  • 5

    KASL clinical practice guidelines for noninvasive tests to assess liver fibrosis in chronic liver disease

    Clinical and Molecular Hepatology 2024 Impact factor 14.0

    Mi Na Kim, Ji Won Han, Jihyun An, Beom Kyung Kim, Young Joo Jin, Seung seob Kim, Minjong Lee, Han Ah Lee, Yuri Cho, Hee Yeon Kim, Yu Rim Shin, Jung Hwan Yu, Moon Young Kim, Young Rok Choi, Young Eun Chon, Eun Ju Cho, Eun Joo Lee, Sang Gyune Kim, Won Kim, Dae Won Jun, Seung Up Kim, on behalf of The Korean Association for the Study of the Liver (KASL)

    Link
  • 4

    Prevalence of clinically significant liver fibrosis in the general population: A systematic review and meta-analysis

    Clinical and Molecular Hepatology 2024 Impact factor 14.0

    Hee Yeon Kim, Jung Hwan Yu, Young Eun Chon, Seung Up Kim, Mi Na Kim, Ji Won Han, Han Ah Lee, Young Joo Jin, Ji Hyun An, Mi Young Choi, Dae Won Jun

    Link
  • 3

    Diagnostic Performance of the Fibrosis-4 Index and Nonalcoholic Fatty Liver Disease Fibrosis Score in Lean Adults With Nonalcoholic Fatty Liver Disease

    JAMA network open 2023 Impact factor 13.8

    Huiyul Park, Eileen L Yoon, Takanori Ito, Ae Jeong Jo, Mimi Kim, Jonghyun Lee, Hye-Lin Kim, Taeang Arai, Masanori Atsukawa, Miwa Kawanaka 10, Hidenori Toyoda, Masatoshi Ishigami, Mig-Lung Yu, Dae Won Jun, Mindie H Nguyen

    Link
  • 2

    Sex Differences in Treatment Response to Nucleos(t)ide Therapy in Chronic Hepatitis B: A Multicenter Longitudinal Study

    Angela Chau, Ming-Lun Yeh, Pei-Chien Tsai, Daniel Q Huang, Sung Eun Kim, Huy Trinh, Eileen L Yoon, Hyunwoo Oh, Jae Yoon Jeong, Sang Bong Ahn, Jihyun An, Cheng-Hao Tseng, Yao-Chun Hsu, Soung Won Jeong, Yong Kyun Cho, Jae-Jun Shim, Hyoung Su Kim, Takanori I 2023 Impact factor 12.6

    Angela Chau, Ming-Lun Yeh, Pei-Chien Tsai, Daniel Q Huang, Sung Eun Kim, Huy Trinh, Eileen L Yoon, Hyunwoo Oh, Jae Yoon Jeong, Sang Bong Ahn, Jihyun An, Cheng-Hao Tseng, Yao-Chun Hsu, Soung Won Jeong, Yong Kyun Cho, Jae-Jun Shim, Hyoung Su Kim, Takanori Ito, Sebastián Marciano, Keigo Kawashima, Takanori Suzuki, Tsunamasa Watanabe, Akito Nozaki, Toru Ishikawa, Kaori Inoue, Yuichiro Eguchi, Haruki Uojima, Hiroshi Abe, Hirokazu Takahashi, Makoto Chuma, Masatoshi Ishigami, Joseph K Hoang, Mayumi Maeda, Chung-Feng Huang, Adrian Gadano, Chia-Yen Dai, Jee-Fu Huang, Yasuhito Tanaka, Wan-Long Chuang, Seng Gee Lim, Ramsey Cheung, Ming-Lung Yu, Dae-Won Jun, Mindie H Nguyen 

    Link
  • 1

    Nomenclature dilemma of metabolic associated fatty liver disease (MAFLD): Considerable proportions of MAFLD are metabolic healthy

    Clinical Gastroenterology and Hepatology 2022 Impact factor 12.6

    Huiyul Park, Eileen L Yoon, Mimi Kim, Seon Cho, Eun-Hee Nah, Dae Won Jun

    Link